Michael Perlman

Title: Michael Perlman: Innovator in Neurological Treatments

Introduction

Michael Perlman is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating neurological injuries and neurodegenerative disorders. His work is characterized by a commitment to advancing medical science through innovative solutions.

Latest Patents

Michael Perlman holds 1 patent for a pharmaceutically active compound and methods of use. This invention pertains to racemic and optically active N-(2-chloro-5-methylthiophenyl)-N′-(3-methylsulfinylphenyl)-N′-methylguanidine, N-(2-chloro-5-methylsulfinylphenyl)-1-(7-trifluoromethyl-1,2,3,4-tetrahydroquinolinyl)carboximidamide, and N-(3-methylsulfinylphenyl)-N-methyl-N′-(2-chloro-5-methoxyphenyl)guanidine, along with their pharmaceutically acceptable salts. The pharmaceutical compositions and therapeutic methods of treatment that comprise these compounds are particularly useful for addressing neurological injuries and neurodegenerative disorders.

Career Highlights

Michael Perlman is associated with Cambridge Neuroscience, Inc., where he continues to push the boundaries of pharmaceutical research. His work has been instrumental in developing new therapeutic approaches that can significantly improve patient outcomes in the field of neurology.

Collaborations

Throughout his career, Michael has collaborated with esteemed colleagues such as Graham J. Durant and James B. Fischer. These partnerships have fostered a collaborative environment that enhances innovation and accelerates the development of new treatments.

Conclusion

Michael Perlman is a dedicated inventor whose work in pharmaceuticals is paving the way for advancements in the treatment of neurological conditions. His innovative compounds and commitment to research exemplify the impact of dedicated inventors in the medical field.